Jinhai Medical Technology Swings to Loss in 2023
Jinhai Medical Technology (HKG:2225) reported a loss attributable to the owners of SG$3.1 million for the year ended Dec. 31, 2023, compared with a profit of about SG$468,000 in the previous year, acc
今海醫療科技:二零二三年年報
Jinhai Medical Technology (02225) subsidiary plans to acquire a property for SGD 10.18 million
Jinhai Medical Technology (02225) issued an announcement. On May 17, 2023, the buyer KT&T...
Jinhai Medical Technology (02225.HK): Zheng Yuan was appointed as company secretary
Gelonghui, April 2, 丨 Jinhai Medical Technology (02225.HK) announced that Zheng Yuan has been appointed as company secretary, effective April 2, 2024.
Jinhai Medical Technology (02225.HK): Net loss of SGD 3.141,000 in 2023
On March 28, GLONGHUI | Jinhai Medical Technology (02225.HK) announced that for the year ended December 31, 2023, revenue was approximately SGD 45.644,000, up about 105% year on year; loss attributable to company owners was approximately SGD 3.141 million, profit attributable to company owners was approximately SGD 468,000; basic loss per share was SGD 0.25.
JINHAI MED TECH: Announcement of Annual Results for the Year Ended 31 December 2023
Jinhai Medical Technology (02225.HK) Profit Alert: Expected annual net loss of 3.5 million to 4.5 million Singapore dollars
On March 22, GLONGHUI | Jinhai Medical Technology (02225.HK) announced that the company expects to record a net loss of SGD 3.5 million to SGD 4.5 million for the year ending December 31, 2023, compared with net profit of SGD 0.12 million for the previous year. The expected shift from net profit to net loss is mainly due to the following reasons: 1. After the board of directors previously re-evaluated its business priorities and strategic direction, the Group actively developed minimally invasive surgery solutions and related medical products and services in China. As a result, there were a number of early product development and test manufacturing costs. During the reporting period there were
今海醫療科技:盈利警告
There's Reason For Concern Over Jinhai Medical Technology Limited's (HKG:2225) Massive 31% Price Jump
Jinhai Medical Technology Limited (HKG:2225) shareholders have had their patience rewarded with a 31% share price jump in the last month. Looking further back, the 22% rise over the last twelve mon
Jinhai Medical Technology (02225.HK) plans to hold a board meeting on March 27 to approve annual results
Glonghui March 15 | Jinhai Medical Technology (02225.HK) announced that it will hold a board meeting on March 27, 2024 to consider and approve (including) the announcement of the company's and its subsidiaries' annual results for the year ended 31 December 2023 and the payment of a final dividend (if applicable).
JINHAI MED TECH: Date of Board Meeting
Jinhai Medical Technology (02225): Chen Guobao has been appointed as authorized representative
Jinhai Medical Technology (02225) issued an announcement that Shi Junbai has resigned as the company secretary; and according to Hong Kong law, China...
Jinhai Medical Technology (02225.HK): Shi Junbai resigns as company secretary
Gelonghui March 14 | Jinhai Medical Technology (02225.HK) issued an announcement. Shi Junbai has resigned as company secretary and authorized representative of the company, effective March 14, 2024. Chairman of the Board and Executive Director Chen Guobao has been appointed as an authorized representative under the Listing Rules, while Hong Jingjing, an employee of the Group, has been appointed as an authorized representative under the Hong Kong Companies Ordinance to replace Ms. Shi, effective from March 14, 2024.
Jinhai Medical Technology Limited's (HKG:2225) Stock Price Dropped 15% Last Week; Individual Investors Would Not Be Happy
Key Insights The considerable ownership by individual investors in Jinhai Medical Technology indicates that they collectively have a greater say in management and business strategy 49% of the compan
Jinhai International Group Renamed As Jinhai Medical Technology
Jinhai International Group Holdings (HKG:2225) has changed its English name to 'Jinhai Medical Technology Limited', according to a Friday filing. The English short stock name on the Hong Kong bourse w
Jinhai International [02225] now reports HK$3, an increase of 14.50%
As of 11:58, Jinhai International [02225] reported HK$3, up HK$0.38 or 14.50% from yesterday's closing price, with a turnover of HK$1,778,400, today's highest price of HK$3 and the lowest price of HK$2.61. Based on yesterday's closing price, the 10-day average price was HK$2.84, and the 50-day average price was HK$2.55. The current price-earnings ratio was 1190.91 times, and the 14-day strong and weak index reported 50.92.
Jinhai International (02225) stock abbreviation changed to “Jinhai Medical Technology”
Zhitong Finance App News, Jinhai International (02225) issued an announcement. After passing a special resolution at the special shareholders' meeting held on December 20, 2023, the Registrar of Companies of the Cayman Islands issued a company registration certificate to change the name on December 28, 2023, certifying that the company's English name was changed from “Jinhai International Group Holdings Limited” to “Jinhai Medical Technology Limited” and that the company was changed The dual foreign name is “Imami
Jinhai International Group Holdings Limited (HKG:2225) Stock Rockets 50% As Investors Are Less Pessimistic Than Expected
Jinhai International Group Holdings Limited (HKG:2225) shareholders have had their patience rewarded with a 50% share price jump in the last month. Looking back a bit further, it's encouraging to s
Jinhai International (02225.HK) granted a total of 129 million share options
Gelonghui, January 9, 丨 Jinhai International (02225.HK) announced that on January 9, 2024, the board of directors (in addition to Wang abandoning the vote on the grant of the share option) decided to grant the grantor a total of 129 million share options under the terms of the share option plan. Of these, 71,087,500 share options were conditionally granted to Liu, 6,462,500 share options were granted to Wang, and 51,700,000 share options were granted to nine other full-time employees of the Group, subject to acceptance or rejection. Conditional grants are subject to shareholders' approval at a special shareholders' meeting.
Jinhai International (02225.HK): Liu Lei was appointed as Group Chief Scientific Officer
Gelonghui, January 8, 丨 Jinhai International (02225.HK) announced that Liu Lei (director and general manager of Shanghai Jinhai Medical Technology Co., Ltd., an indirect wholly-owned subsidiary of the company) was appointed as the Group's Chief Scientific Officer, effective from December 1, 2023. The initial term is three years. He is mainly responsible for obtaining certificates and research and development for Jinhai Medical's products, and supervising the implementation of other new products and technologies to ensure that they will meet the Group's long-term development strategy.
No Data